Indexed In
- Open J Gate
- Academic Keys
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Centre for Agriculture and Biosciences International (CABI)
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- CABI full text
- Publons
- Geneva Foundation for Medical Education and Research
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Amit Kumar Das
Diabetologist, Shree Hospital and Maternity, Muzaffarpur, Bihar, India
Biography
Dr. Amit Kumar Das is an active researcher at the Shree Hospital and Maternity, Muzaffarpur, Bihar, India. He also serves as MBBS at the same department and has done much research works in the field of COVID-19.
Publications
-
Review
Favipiravir: Promising Therapy for COVID-19
Author(s): Amit Kumar Das*
COVID 19 is become one of the most threatened pandemics in recent time and spreading rapidly. Favipiravir, an antiviral drug, has shown promising but yet unproven effect against COVID-19 infection. Drug Controller General of India (DCGI) has recently approved Favipiravir for treating moderate to severe COVID-19 infected patients. Favipiravir, a broad-spectrum antiviral drug that interferes with the viral replication and emerging as promising therapeutic potential as indicated by initial clinical studies. In this literature review author tries to summaries an overview of Favipiravir as a promising therapy for COVID-19 disease. .. View more»